[Anaesthesia for endocrine tumor removal]

Area of Science:

• Endocrinology
• Surgical Oncology
• Anesthesiology

Context:

• Endocrine tumors present unique challenges due to hormone and protein production.
• Physiological alterations and adverse events associated with these tumors require specialized knowledge.
• A comprehensive understanding is vital for early intervention and improved patient outcomes.

Purpose:

• To review changes induced by endocrine tumors.
• To describe preoperative assessment strategies.
• To discuss intraoperative monitoring and anesthetic drug choices for endocrine tumors.

Summary:

• Preoperative blood pressure control is critical for phaeochromocytoma surgery, followed by intensive fluid management and specific medications during anesthesia.
• Post-thyroidectomy complications include hematoma and recurrent laryngeal nerve injury.
• Pituitary surgery risks include air embolism and postoperative complications like diabetes insipidus and CSF leaks. Acromegaly may cause intubation difficulties, while Cushing's syndrome can lead to cardiac failure and infections.
• Somatostatin analogs are key in managing carcinoid tumors preoperatively and during anesthesia.

Impact:

• Provides evidence-based guidance for optimizing patient care and reducing perioperative risks.
• Highlights the importance of multidisciplinary collaboration in managing complex endocrine tumors.
• Aims to improve surgical outcomes and patient safety through informed anesthetic and surgical planning.